Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas — Stella

Home/Basal Cell Carcinoma (BCC)/

View on ClinicalTrials.gov

Recruiting

Back to Basal Cell Carcinoma (BCC) trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Medical Dermatology Specialists, Phoenix, Arizona

Key details

Phase

Early testing

Sponsor

Nathalie Zeitouni

Enrollment target

~20 participants

Started

October 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.